Co-Diagnostics, Inc. (CODX) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 3.65M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $3.65M | (m) | (m) |
| 2026-03-31 | (m) | (m) | $8.23M | (m) | (m) |
| 2025-12-31 | (m) | (m) | $11.88M | (m) | (m) |
| 2025-09-30 | (m) | (m) | $11.44M | (m) | (m) |
| 2025-06-30 | $13.36M | (m) | $11.12M | $2.25M | (m) |
| 2025-03-31 | $21.48M | (m) | $1.90M | $19.58M | (m) |
| 2024-12-31 | $29.75M | (m) | $2.94M | $26.81M | (m) |
| 2024-09-30 | $37.66M | (m) | $10.80M | $26.86M | (m) |
| 2024-06-30 | $44.88M | (m) | $13.86M | $31.02M | (m) |
| 2024-03-31 | $49.96M | (m) | $23.10M | $26.86M | (m) |
| 2023-12-31 | $58.55M | (m) | $14.92M | $43.63M | (m) |
| 2023-09-30 | $63.43M | (m) | $10.24M | $53.19M | (m) |
| 2023-06-30 | $69.14M | (m) | $13.83M | $55.31M | (m) |
| 2023-03-31 | $75.28M | (m) | $6.36M | $68.92M | (m) |
| 2022-12-31 | $81.26M | (m) | $22.97M | $58.29M | (m) |
| 2022-09-30 | $86.49M | (m) | $81.51M | $4.98M | (m) |
| 2022-06-30 | $96.00M | (m) | $86.05M | $9.95M | (m) |
| 2022-03-31 | (m) | (m) | $97.42M | (m) | (m) |
| 2021-12-31 | $89.86M | (m) | $88.61M | $1.26M | (m) |
| 2021-09-30 | $83.91M | (m) | $82.66M | $1.25M | (m) |
| 2021-06-30 | $72.38M | (m) | $70.27M | $2.11M | (m) |
| 2021-03-31 | $60.09M | (m) | $57.79M | $2.30M | (m) |
| 2020-12-31 | $47.31M | (m) | $42.98M | $4.34M | (m) |
| 2020-09-30 | $27.28M | (m) | $21.23M | $6.05M | (m) |
| 2020-06-30 | (m) | (m) | $18.55M | (m) | (m) |
| 2020-03-31 | (m) | (m) | $17.37M | (m) | (m) |
| 2019-12-31 | (m) | (m) | $893.14K | (m) | (m) |
| 2019-09-30 | (m) | (m) | $2.54M | (m) | (m) |
| 2019-06-30 | (m) | (m) | $3.86M | (m) | (m) |
| 2019-03-31 | (m) | (m) | $5.41M | (m) | (m) |
| 2018-12-31 | (m) | (m) | $950.24K | (m) | (m) |
| 2018-09-30 | (m) | (m) | $2.18M | (m) | (m) |
| 2018-06-30 | (m) | (m) | $1.53M | (m) | (m) |
| 2018-03-31 | (m) | (m) | $2.54M | (m) | (m) |
| 2017-12-31 | (m) | (m) | $3.53M | (m) | (m) |
| 2017-09-30 | (m) | (m) | $4.63M | (m) | (m) |
| 2017-06-30 | (m) | (m) | $116.77K | (m) | (m) |
| 2017-03-31 | (m) | (m) | $496.45K | (m) | (m) |
| 2016-12-31 | (m) | (m) | $998.74K | (m) | (m) |
| 2016-09-30 | (m) | (m) | $53.37K | (m) | (m) |
| 2016-06-30 | (m) | (m) | $1.47K | (m) | (m) |
| 2015-12-31 | (m) | (m) | $33.80K | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |